Effectiveness of enhanced recovery after surgery among cancer patients: A meta-analysis of randomized controlled trials.
Linna Li, Min Hu, Qianwen Yan et al.
✦ AI-curated · Sources linked
In 30 seconds
This meta-analysis of randomized controlled trials evaluated the effectiveness of enhanced recovery after surgery (ERAS) in cancer patients. The analysis included 67 studies and found that ERAS significantly improved physiological indicators, reduced postoperative complications (RR = 0.60), and enhanced overall survival (HR = 0.68) compared to conventional care. ERAS also led to shorter hospital stays and lower hospitalization costs.
Key findings
- ERAS reduced postoperative complications with a relative risk of 0.60 (0.52, 0.68).
- Overall survival improved with ERAS, showing a hazard ratio of 0.68 (0.47, 0.98).
- Patients experienced less pain on the first postoperative day with a standardized mean difference of -1.00 (-1.45, -0.56).
- Hospitalization fees were reduced in the ERAS group with a standardized mean difference of -0.60 (-0.79, -0.41).
Why it matters
The findings suggest that implementing ERAS protocols can lead to improved patient outcomes and resource efficiency in surgical oncology. This approach may enhance recovery and reduce healthcare costs, which is crucial in managing cancer care effectively.